AB-343
AB-343 is a selective covalent inhibitor of SARS-CoV-2 Mpro, with an IC50 of 8 nM and a Ki of 2.8 nM. AB-343 can effectively inhibit the main proteases of SARS-CoV-2 and many other coronaviruses, and is also active against some resistant variants. AB-343 can be used in the research of treating coronavirus infection-related diseases[1][2].
Product Specifications
CAS Number
3077209-48-1
UNSPSC
12352005
Target
SARS-CoV; Virus Protease
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Smiles
O=C([C@H](NC(C(F)(F)F)=O)CC1CCC1)N2[C@H]3CC[C@@H]([C@H]2C(N[C@H](C#N)C[C@H]4CC(C)(NC4=O)C)=O)C(F)(F)C3
Molecular Formula
C26H34F5N5O4
Molecular Weight
575.57
References & Citations
[1]McGovern-Gooch KR, et al. Biological characterization of AB-343, a novel and potent SARS-CoV-2 Mpro inhibitor with pan-coronavirus activity. Antiviral Res. 2024 Dec;232:106038.|[2]Mason J D, et al. Development of a Scalable Manufacturing Process for AB-343 Drug Substance: A Potential Candidate for the Treatment of Coronavirus Infections. Organic Process Research & Development, 2025.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
207811-HRP 100 µL
NCOA4 (Nuclear Receptor Coactivator 4, ARA70, DKFZp762E1112, ELE1, PTC3, RFG) (HRP)
Sign In for Pricing
View Details HC336106-01 100 µg
Research Grade Anti-Human CD137/TNFRSF9/4-1BB (AGEN 2373)
Sign In for Pricing
View Details